Thales Dis Ais Deutschland v. 3G Licensing: Federal Circuit Reverses CQI Patent Ruling
Thales Dis Ais Deutschland GmbH secured a reversal at the Federal Circuit against 3G Licensing, S.A. over US7319718B2, a patent covering CQI coding methods for the HS-DPCCH uplink channel in 3G wireless standards. The appeal ran 721 days before the Federal Circuit found reversible error in the patentability determination below.
Federal Circuit overturns CQI patent invalidity ruling in 3G standards dispute
Filed on January 12, 2023, Case No. 23-1384 brought Thales Dis Ais Deutschland GmbH before the Court of Appeals for the Federal Circuit as appellant, challenging a prior patentability determination adverse to US7319718B2. That patent, applied under application number US10/365498, covers a CQI (Channel Quality Indicator) coding method for the HS-DPCCH — the high-speed dedicated physical control channel used in 3G WCDMA/HSPA wireless systems. The patent sits at the intersection of cellular standards and proprietary signal-processing IP, a commercially sensitive zone given the prevalence of HSPA-capable chipsets and devices.
On January 2, 2025, the Federal Circuit issued its judgment: REVERSED. The verdict cause was patentability — specifically an invalidity or cancellation action — and the court’s order determined that the lower tribunal had committed reversible error in that assessment. A reversal at this level means the prior decision no longer stands; the patent’s challenged claims are not invalidated by the reasoning applied below, and the dispute is resolved in Thales’s favour on the appellate record as it stood.
The 721-day duration is consistent with a substantive Federal Circuit appeal involving technical claim construction or prior art analysis, rather than a purely procedural disposition. The public record does not disclose the precise grounds for reversal — whether the tribunal below misapplied the prior art standard, erred on claim construction, or committed a procedural error — leaving open questions about the precise doctrinal basis. What is clear is that the reversal strengthens Thales’s position as the effective holder of enforceable rights in US7319718B2 against future challenges by 3G Licensing.
Filing to Case Reversed in 721 days
721 days at the Federal Circuit — appellate patent cases typically resolve in 18–24 months
Federal Circuit reverses: what the ruling means for both parties
What ‘REVERSED’ means at the Federal Circuit
A reversal by the Federal Circuit means the appellate court found that the tribunal below committed reversible legal error in its patentability determination. The prior decision — which had gone against the patent’s validity — is nullified. The Federal Circuit’s ruling substitutes its own conclusion on the legal question, here resolving the invalidity/cancellation action in the patent holder’s favour. No remand is indicated, suggesting the court resolved the matter on the existing record.
Lower decision overturnedThales emerges with US7319718B2 intact and enforceable
The reversal directly benefits Thales Dis Ais Deutschland GmbH as appellant. The invalidity or cancellation action brought against US7319718B2 has failed at the highest available patent appellate court in the US system. The patent’s challenged claims survive this proceeding, restoring — or confirming — enforceability. Thales is now in a stronger position to assert, license, or defend this CQI coding patent against third parties operating in the HS-DPCCH space.
Patent claims survive challenge3G Licensing’s invalidity strategy fails at Federal Circuit level
3G Licensing, S.A., as appellee defending the lower tribunal’s invalidity finding, has exhausted its appellate options at the Federal Circuit on the grounds raised in this proceeding. The reversal forecloses reliance on the prior adverse ruling. Further challenge would require either a petition for en banc rehearing or certiorari to the US Supreme Court — both high-bar paths. The commercial leverage gained from the lower invalidity determination is eliminated by this outcome.
Appellate avenue exhaustedStrengthened CQI patent raises licensing pressure across 3G/HSPA supply chain
US7319718B2 covers CQI coding for HS-DPCCH — a signalling mechanism embedded in WCDMA/HSPA chipsets, handsets, and infrastructure. The Federal Circuit’s reversal signals that the patent withstands rigorous appellate scrutiny, consistent with a higher litigation risk profile for device makers, chipset vendors, and network operators who have not yet addressed this patent. Companies with products implementing HS-DPCCH uplink signalling should assess their exposure in light of this outcome.
Elevated enforcement riskFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Thales Dis Ais Deutschland, GmbH | Company | Telecommunications IP entity — holder of US7319718B2 covering CQI coding for HS-DPCCHSearch in Eureka ↗ |
| Defendant | 3G Licensing, S.A. | Individual | 3G Licensing, S.A. — patent licensing entity asserting invalidity of 3G wireless standard IPSearch in Eureka ↗ |
| Plaintiff counsel | Meredith Martin Addy | Attorney | Counsel for Thales Dis Ais Deutschland, GmbHSearch in Eureka ↗ |
| Plaintiff law firm | Addyhart, PC | Law Firm | Representing Thales Dis Ais Deutschland, GmbHSearch in Eureka ↗ |
| Defendant counsel | Timothy Devlin | Attorney | Counsel for 3G Licensing, S.A.Search in Eureka ↗ |
| Defendant law firm | Devlin Law Firm LLC | Law Firm | Representing 3G Licensing, S.A.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
Official order — verbatim text
The Federal Circuit’s order — ‘REVERSED’ on a verdict cause of patentability in an invalidity/cancellation action — carries significant legal weight. At the appellate level, reversal requires the court to find that the tribunal below committed an error of law, not merely that the appellate panel would have weighed facts differently. The de novo standard typically applies to claim construction; clear error applies to underlying factual findings. The unqualified reversal, with no remand instruction visible in the public record, suggests the Federal Circuit resolved the patentability question in Thales’s favour as a matter of law on the record as constituted, rather than returning it for further fact-finding.
US7319718B2 — CQI coding method for HS-DPCCH uplink signalling
US7319718B2, filed under application number US10/365498, protects a method for encoding Channel Quality Indicator (CQI) information on the HS-DPCCH — the uplink control channel introduced in 3GPP Release 5 to support HSDPA (High Speed Downlink Packet Access). CQI reports are transmitted by user equipment to the base station to signal downlink channel conditions, enabling adaptive modulation and coding. The patent’s claims relate to how this CQI information is coded and structured on the uplink, placing it at the heart of HSPA radio link performance.
Patents covering physical-layer control channel coding in cellular standards occupy a strategically valuable position: they are difficult to design around without breaking interoperability with standards-compliant infrastructure. US7319718B2’s relevance extends to any device or chipset implementing HSDPA — a technology embedded in billions of handsets, modules, and infrastructure units sold since the mid-2000s. The Federal Circuit’s reversal of the invalidity finding reinforces the patent’s enforceability and increases the commercial risk for implementers who have not secured a licence or conducted a thorough freedom-to-operate analysis.
Should you run an FTO analysis against US7319718B2?
Any organisation developing, manufacturing, or distributing products that implement HSDPA or HSPA uplink control channel signalling — including handset OEMs, chipset vendors, wireless module makers, and network equipment providers — should assess their position against US7319718B2 following the Federal Circuit’s reversal. The patent covers a low-level CQI coding procedure that is functionally required for HS-DPCCH operation, meaning design-around options may be structurally limited by 3GPP standards compliance requirements.
PatSnap Eureka’s FTO Search Agent enables R&D and IP teams to rapidly map claim scope against product specifications, identify relevant prosecution history, and surface comparable CQI and HS-DPCCH patents in the same family or competitive landscape. With the Federal Circuit having confirmed the patent’s survival in adversarial proceedings, a formal FTO review is a proportionate and defensible step for any HSPA-capable product team operating in the US market.
Run a freedom-to-operate analysis on US7319718B2 to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit appeals involving 3G/HSPA wireless standard patents
Explore Federal Circuit decisions involving CQI coding, HS-DPCCH signalling, and 3G standard-essential patent validity challenges in comparable appeal proceedings.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable CQI coding method for HS-DPCCH-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedThales Dis Ais Deutschland, GmbH’s broader IP enforcement history
Thales Dis Ais Deutschland, GmbH’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this reversal signals for 3G/HSPA standard-essential patent disputes
A Federal Circuit reversal on CQI coding IP resets the enforcement landscape for HS-DPCCH-related patents across the wireless supply chain.
Standard-adjacent patents can survive aggressive invalidity campaigns
US7319718B2 covers a method tightly coupled to 3G WCDMA standards. 3G Licensing’s invalidity action failed at the Federal Circuit, suggesting that claim scope or prosecution history presented a higher-than-expected validity bar. Companies treating standards-related patents as inherently weak should reassess their IPR and cancellation strategies in light of this result.
Reversal without remand signals a clean record-based win for Thales
The Federal Circuit appears to have resolved the patentability question on the existing appellate record rather than returning it to the lower tribunal. This is a stronger outcome than a remand for further proceedings — it suggests the error below was clear and the corrected result was determinable. For licensing negotiations, this distinction matters: the patent is not in limbo awaiting further proceedings.
Which HS-DPCCH implementers face the highest post-reversal licensing exposure
With US7319718B2 now judicially confirmed as valid at the Federal Circuit, chipset vendors and OEMs shipping HSPA-enabled devices into the US market face materially elevated licensing risk. The CQI coding method is a low-level channel procedure — workarounds at the product level are constrained by interoperability requirements with standards-compliant base stations.
Prosecution history and claim construction arguments that drove the reversal
Federal Circuit reversals on patentability frequently hinge on de novo claim construction or clear error in prior art characterisation. The specific doctrinal ground here is not public, but the outcome is consistent with the lower tribunal having applied an overly broad anticipation or obviousness reading. Competitors monitoring this patent should examine the appellate briefs for the operative claim language.
Thales v 3G — key questions answered
The Federal Circuit reversed the lower tribunal’s patentability determination in Case No. 23-1384, decided January 2, 2025. The invalidity/cancellation action against US7319718B2 — a CQI coding patent for HS-DPCCH — was overturned on appeal, restoring the patent’s validity as a matter of Federal Circuit law.
US7319718B2 covers a method for coding Channel Quality Indicator (CQI) information on the HS-DPCCH uplink channel in 3G WCDMA/HSPA systems. CQI reports are mandatory for HSDPA operation — they enable adaptive modulation at the base station. The patent’s scope potentially reaches any device or chipset implementing standards-compliant HSDPA uplink signalling, making it relevant across handsets, wireless modules, and network infrastructure.
A Federal Circuit reversal on patentability nullifies the adverse invalidity/cancellation ruling below. US7319718B2’s challenged claims are not invalidated by this proceeding. The patent is enforceable in the US, and the reversal — without a remand — suggests the Federal Circuit resolved the question definitively on the record. 3G Licensing’s further challenge options are limited to en banc rehearing or Supreme Court certiorari.
Thales Dis Ais Deutschland GmbH is the appellant and patent holder, asserting the validity of US7319718B2 covering CQI coding for HS-DPCCH. 3G Licensing, S.A. is a patent licensing entity that brought or defended an invalidity/cancellation action against the patent. The Federal Circuit found in Thales’s favour, reversing the prior adverse patentability ruling.
Following the reversal, US7319718B2 carries enhanced enforceability. Companies with HSPA-enabled products — OEMs, chipset designers, module manufacturers — face increased FTO risk in the US market. The CQI coding method at issue is operationally integral to HS-DPCCH function, limiting design-around options constrained by 3GPP interoperability requirements. A formal FTO and patent landscape review is advisable for affected product teams.
Monitor 3G/HSPA patent enforcement risk after this Federal Circuit reversal
US7319718B2 is now appellate-validated. Run an FTO analysis against HS-DPCCH CQI coding claims and set enforcement alerts for related 3G standard patent activity using PatSnap Eureka.
PatSnap Eureka searches patents and litigation data to answer instantly.